Published in Clin Chem on March 26, 2010
Kisspeptins in human reproduction-future therapeutic potential. J Assist Reprod Genet (2012) 0.75
Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 8.30
Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med (2003) 5.83
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int (2009) 4.61
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg (2006) 4.30
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med (2011) 3.93
AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem (2004) 3.84
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension (2013) 3.33
Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab (2005) 3.08
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg (2007) 3.02
Gut hormones and the regulation of energy homeostasis. Nature (2006) 2.53
Maternal mortality in the UK and the need for obstetric physicians. BMJ (2011) 2.51
The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res (2005) 2.19
Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology (2010) 2.18
Intrahepatic cholestasis of pregnancy. World J Gastroenterol (2009) 2.12
Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J (2005) 2.03
Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut (2013) 2.01
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.97
Are 1st-trimester β-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels predictive of intrapartum fetal compromise in a selected normal population? Aust N Z J Obstet Gynaecol (2014) 1.96
Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group. J Neurol Neurosurg Psychiatry (2013) 1.83
Gastric bypass increases energy expenditure in rats. Gastroenterology (2009) 1.79
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int (2009) 1.78
An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology (2008) 1.76
Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet (2012) 1.72
The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology (2012) 1.70
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain (2010) 1.67
Effects of exercise on gut peptides, energy intake and appetite. J Endocrinol (2007) 1.61
Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest (2014) 1.58
PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction randomised controlled trial. BJOG (2007) 1.55
The importance of cysteine cathepsin proteases for placental development. J Mol Med (Berl) (2006) 1.54
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes (2005) 1.52
Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease. Clin Endocrinol (Oxf) (2012) 1.50
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica (2009) 1.49
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology (2005) 1.49
Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology (2006) 1.49
Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays. Clin Endocrinol (Oxf) (2012) 1.47
Fetal cystoscopy in the management of fetal obstructive uropathy: experience in a single European centre. Prenat Diagn (2003) 1.46
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci U S A (2012) 1.46
Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab (2007) 1.46
Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology (2007) 1.46
Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology (2014) 1.45
Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol (2011) 1.44
Endocrine disease in pregnancy. Clin Med (2013) 1.41
Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg (2010) 1.39
Amniocentesis in the third trimester of pregnancy. Prenat Diagn (2007) 1.39
Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab (2005) 1.38
Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab (2009) 1.38
Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev (2006) 1.38
Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab (2003) 1.35
The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab (2011) 1.35
Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells (2005) 1.34